Clinical Trial Update: A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial of ABSK061 in children with achondroplasia is reported, and recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Achondroplasia

Drugs mentioned

• ABSK061

Snippet

Sponsor: Abbisko Therapeutics Co, Ltd | Conditions: Achondroplasia | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING